Clinical Trials Logo

Skin Conditions clinical trials

View clinical trials related to Skin Conditions.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04456829 Completed - Skin Conditions Clinical Trials

Investigation of the Efficacies of a Resveratrol Formula on Improvement of Skin Conditions and Inflammatory Related Factors

Resveratrol
Start date: September 17, 2020
Phase: N/A
Study type: Interventional

To assess a resveratrol formula on improvement of skin conditions and inflammatory cytokines in blood

NCT ID: NCT01899287 Completed - Eczema Clinical Trials

A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand Eczema

PREVEX
Start date: July 2012
Phase: N/A
Study type: Interventional

Occupational hand eczema (OHE) is a frequent disease which often takes a chronic course. The burden of the disease is high in a personal as well as in a socio-economic context. There is a need for evaluating new strategies to improve the prognosis for OHE patients. The objectives of the study is to evaluate the effect of group education on sick lave, health-related quality of life and disease severity among individuals with newly notified OHE. The trial population consist of individuals from the Capital Region of Denmark and Region Zealand with a suspected skin-related industrial injury notified to the Danish National Board of Industrial Injuries (DNBII). Recruitment is started Juli 2012, and will continue until the designed number of participants have been included. All participants will be assessed in a questionnaire at time T=0 with regard to: self evaluated disease severity, health-related quality of life, skin protective behaviour, knowledge of skin protection, self-efficacy, work-role function and if active in workforce. The participants will then be randomised. The intervention group will be invited to participate in the educative course, and work place visits will be offered. In the intervention group a telephone hot line will be available for further questions concerning these topics. The control group will not have access to any of these interventions. Both intervention group and control group will be contacted every eighth week about number of days of sick leave/absence from workforce. Both groups are re-assessed using a questionnaire at T=12 months. There will be a total of 742 included participants.

NCT ID: NCT01467778 Completed - Skin Conditions Clinical Trials

Safety Study of Three Formulations of the Dermal Implant ELAPR

Start date: December 2010
Phase: Phase 1
Study type: Interventional

This is a Phase I study to assess the safety of three formulations of the dermal implant ELAPR.